Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacks

Hypertension

Volumn 49, Issue 5, 2007, Pages 992-999

  Meyers, Kristin J ^a   Mosley, Thomas H ^b   Fox, Ervin ^b   Boerwinkle, Eric ^c   Arnett, Donna K ^d   Devereux, Richard B ^e   Kardia, Sharon L R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Association; Echocardiography; Left ventricular hypertrophy; Single nucleotide polymorphism; Ventricular remodeling

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENE REPLICATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; COHORT ANALYSIS; ECHOGRAPHY; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; MIDDLE AGED; NEGRO; REPRODUCIBILITY; STATISTICAL MODEL;

APOLIPOPROTEIN E; BETA 1 ADRENERGIC RECEPTOR; SCN7A PROTEIN, HUMAN; SLC20A1 PROTEIN, HUMAN; SODIUM CHANNEL; SODIUM PHOSPHATE COTRANSPORTER 3; UNCLASSIFIED DRUG;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-1; REPRODUCIBILITY OF RESULTS; SODIUM CHANNELS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; VARIATION (GENETICS);

EID: 34247893805     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.106.081265     Document Type: Article

References (34)

1. National Center for Health Statistics. CDC Health, United States, 2005. Hyattsville, MD: US Government Printing Office, 2005.
2. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:2098-2104.
3. Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, Shea S. Racial/ethnic differences in hypertension and hypertension treatment and control in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2004;17:963-970.
4. Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Devereux RB. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network Study. Hypertension. 2004;43:1182-1188.
5. Asia Pacific Cohort Studies Collaboration. The impact of cardiovascular risk factors on the age-related excess risk of coronary heart disease. Int J Epidemiol. 2006;35:1025-1033.
6. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
7. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
8. Palmieri V, Dahlof B, DeQuattro V, Sharpe N, Bella BN, de Simone G, Paranicas M, Fishman D, Devereux RB. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol. 1999;34:1625-1632.
9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Camp E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
10. Arnett DK, de las Fuentes L, Broeckel U. Genes for left ventricular hypertrophy. Curr Hypertens Rep. 2004;6:36-41.
11. Bella JN, Wachtell K, Palmieri V, Liebson PR, Gerdts E, Tlitalo A, Koren MJ, Pederson OL, Rokkedal J, Dahlof B, Roman MJ, Devereux RB. Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE study. Losartan Intervention for Endpoint Reduction in Hypertension Study. J Hypertens. 2001;19:127-134.
12. du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens. 2002;15:222-229.
13. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991;68:85-89.
14. Benjamin EJ, Levy D. Why is left ventricular hypertrophy so predictive of morbidity and mortality? Am J Med Sci. 1999;317:168-175.
15. Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997;30:1025-1028.
16. Swan L, Birnie DH, Padmanabhan S, Inglis G, Connell JM, Hillis WS. The genetic determination of left ventricular mass in healthy adults. Eur Heart J. 2003;24:577-582.
17. Di Nicolantonio R, Kostka V, Kwitek A, Jacob H, Thomas WG, Harrap SB. Fine mapping of Lvm1: a quantitative trait locus controlling heart size independently of blood pressure. Pulm Pharmacol Ther. 2006;19:70-73.
18. Innes BA, McLaughlin MG, Kapuscinski MK, Jacob HJ, Harrap SB. Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension. Hypertension. 1998;31:741-746.
19. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.
20. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet. 2005;366:1315-1323.
21. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered. 2003;56:73-82.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the Am Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
23. Sokal RR, Rohlf FJ. Biometry: The Principles and Practice of Statistics in Biological Research. 3rd ed. New York, NY: WH Freeman and Company, 1994.
24. Falconer DS. Introduction to Quantitative Genetics. 2nd ed. New York, NY: John Wiley & Sons, Inc, 1981.
25. Nunez E, Arnett DK, Benjamin EJ, Liebson PR, Skelton TN, Taylor H, Andrew M. Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities Study. Hypertension. 2005;45:58-63.
26. Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T, Roman MJ, Papademetriou V, Ibsen H, Rokkedal J, Devereux RB. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension. 2000;35:6-12.
27. Arnett DK. Genetic contributions to left ventricular hypertrophy. Curr Hypertens Rep. 2000;2:50-55.
28. Deng HW, Chen WM, Recker RR. Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics. 2001;157:885-897.
29. Lee WC. Searching for disease-susceptibility loci by testing for Hardy-Weinberg Disequilibrium in a gene bank of affected individuals. Am J Epidemiol. 2003;158:397-400.
30. Nielsen DM, Ehm MG, Weir BS. Detecting marker disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet. 1999;63:1531-1540.
31. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4:45-61.
32. Hoffjan S, Nicolae D, Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res. 2003;4:14.
33. 2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002;347:1135-1142.
34. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB. Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Hum Mutat. 1999;14:271.